
PFF Group NV acquires stake in Autolus Therapeutics
With the investment into London-headquartered Autolus Therapeutics, PPF Group N.V. significantly increased its commitment to the healthcare sector....

Researchers identify CTLA-4 response marker
The research team headed by Simon Heideger and Hendrick Poeck from Technical University of Munich together with colleagues from Memorial Sloan...

Evotec and Celmatix enter strategic partnership
Under the terms of the strategic R&D collaboration, Celmatix Inc. (New York) will utilise its proprietary multi-omics Reproductive Atlas platform...

Rotavirus vaccines kill cancer cells
The team headed by Aurelian Marabelle discovered in mice that commercially available vaccines against rotavirus – which causes diarrhea in children...

Rottapharm Biotech: POC in osteoarthritis pain
Results of the proof-of-concept trial suggest the selective imidazoline-2 (I2) receptor agonist CR4056 could be an alternative to the...

NSCLC: Bemcentinib + anti-PD1 triple PFS
Bergen Bio ASA announced the primary endpoint of 25% Overall Response Rate (ORR) has been met in predominantly PD-L1 negative/low NSCLC patients in a...

Researchers unravel how ADEP antibiotics work
Fighting antimicrobial resistance has been named one of the prioritary goals by the World Health Organization (WHO). However, as the number of...